View of EVALUATION OF 5-YEAR SURVIVAL OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH STAGE III NON-SMALL CELL LUNG CANCER TREATED WITH CONCURRENT CHEMORADIOTHERAPY AT NGHE AN ONCOLOGY HOSPITAL

Return to Issue Details EVALUATION OF 5-YEAR SURVIVAL OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH STAGE III NON-SMALL CELL LUNG CANCER TREATED WITH CONCURRENT CHEMORADIOTHERAPY AT NGHE AN ONCOLOGY HOSPITAL Download Download PDF